Results
2508
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,508 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
UNH | US$493.48 | 5.7% | 0.9% | US$451.4b | US$629.96 | PE31.3x | E18.7% | 1.7% | Healthcare | ||
ORCL | US$155.16 | -4.2% | 36.0% | US$434.0b | US$194.82 | PE37.3x | E15.6% | 1.0% | Software | ||
JNJ | US$166.69 | -0.4% | 3.4% | US$401.3b | US$169.07 | PE28.5x | E7.9% | 3.0% | Pharmaceuticals & Biotech | ||
BX | US$145.15 | -8.4% | 16.5% | US$177.3b | US$183.19 | PE40.2x | E24.6% | 2.7% | Diversified Financials | ||
AMD | US$100.31 | 2.1% | -49.4% | US$162.6b | US$148.34 | PE99.1x | E32.0% | n/a | Semiconductors | ||
PFE | US$26.73 | 1.8% | -5.8% | US$151.5b | US$31.04 | PE18.9x | E3.9% | 6.4% | Pharmaceuticals & Biotech | ||
LOW | US$242.66 | -1.4% | 0.7% | US$135.9b | US$279.42 | PE19.6x | E6.2% | 1.9% | Retail | ||
BHP | AU$39.20 | -1.0% | -8.5% | AU$198.8b | AU$44.63 | PE11x | E-0.4% | 4.0% | Materials | ||
BMY | US$61.09 | 2.0% | 12.4% | US$124.0b | US$61.24 | PS2.6x | E33.3% | 4.1% | Pharmaceuticals & Biotech | ||
COP | US$90.63 | -2.2% | -21.4% | US$115.3b | US$129.52 | PE12.5x | E4.4% | 3.4% | Energy | ||
RIO | UK£48.29 | -1.0% | 0.4% | UK£81.7b | UK£57.59 | PE8.8x | E-0.1% | 6.5% | Materials | ||
INVE A | SEK 307.50 | -5.0% | 18.2% | SEK 957.3b | SEK 315.00 | PE8.3x | E-48.3% | 1.7% | Diversified Financials | ||
ENB | CA$60.38 | -2.4% | 24.3% | CA$131.6b | CA$64.43 | PE26x | E10.4% | 6.2% | Energy | ||
RR. | UK£7.33 | -5.7% | 91.2% | UK£67.3b | UK£7.78 | PE24.4x | E2.5% | 0.8% | Capital Goods | ||
1299 | HK$62.80 | 6.4% | 0.9% | HK$669.2b | HK$92.23 | PE17.8x | E13.8% | 2.6% | Insurance | ||
BP. | UK£4.18 | -3.3% | -11.3% | UK£65.8b | UK£4.91 | PE220.2x | E24.0% | 5.9% | Energy | ||
ATCO A | SEK 179.15 | -1.2% | 0.03% | SEK 855.5b | SEK 187.30 | PE29.3x | E6.7% | 1.7% | Capital Goods | ||
CVS | US$66.33 | 2.2% | -12.7% | US$83.6b | US$72.46 | PE18.1x | E14.4% | 4.0% | Healthcare | ||
IBKR | US$192.17 | -4.6% | 78.4% | US$81.2b | US$228.00 | PE27.7x | E2.6% | 0.5% | Diversified Financials | ||
GSK | UK£15.59 | 5.3% | -7.0% | UK£62.5b | UK£18.12 | PE24.7x | E18.1% | 3.9% | Pharmaceuticals & Biotech | ||
PNC | US$179.77 | -5.1% | 17.6% | US$71.1b | US$218.88 | PB1.5x | E10.0% | 3.6% | Banks | ||
BBCA | Rp8,925.00 | 1.4% | -12.1% | Rp1100.2t | Rp11,598.36 | PB4.2x | E7.7% | 3.1% | Banks | ||
WBC | AU$30.40 | -4.4% | 13.3% | AU$104.1b | AU$28.58 | PB1.5x | E1.1% | 5.0% | Banks | ||
SPG | US$171.10 | -8.9% | 14.2% | US$64.5b | US$190.89 | PB19.2x | E1.0% | 4.9% | Real Estate |